Literature DB >> 11591711

Constitutive activation of extracellular signal-regulated kinase 2 by synergistic point mutations.

M A Emrick1, A N Hoofnagle, A S Miller, L F Ten Eyck, N G Ahn.   

Abstract

Constitutively active mutant forms of signaling enzymes provide insight into mechanisms of activation as well as useful molecular tools for probing downstream targets. In this study, point mutations in ERK2 at conserved residues L73P and S151D were identified that individually led to 8-12-fold increased specific activity and in combination reached 50-fold, indicating synergistic interactions between these residues. Examination by mass spectrometry, phosphatase sensitivity, and Western blotting revealed that the mutations enhanced ERK2 activity by facilitating intramolecular autophosphorylation predominantly at Tyr-185 and to a lesser extent at Thr-183 and that phosphorylation at both sites is required for activation. A set of short molecular dynamics simulations were carried out using different random seeds to sample locally accessible configurations. Simulations of the active mutant showed potential hydrogen bonding interactions between the phosphoryl acceptor and catalytic nucleophile, which could account for enhanced intramolecular autophosphorylation. In intact cells, the ERK2 mutants were functionally active in phosphorylating Elk-1 and RSK1 and activating the c-fos promoter. This activity was only partially reduced upon treatment of cells with the MKK1/2 inhibitor, U0126, indicating that in vivo the mechanism of ERK2 activation occurs substantially through autophosphorylation and partially through phosphorylation by MKK1/2.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11591711     DOI: 10.1074/jbc.M107708200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  31 in total

1.  Phosphorylation-dependent changes in structure and dynamics in ERK2 detected by SDSL and EPR.

Authors:  Andrew N Hoofnagle; James W Stoner; Thomas Lee; Sandra S Eaton; Natalie G Ahn
Journal:  Biophys J       Date:  2004-01       Impact factor: 4.033

2.  Central role of protein kinase Cepsilon in constitutive activation of ERK1/2 and Rac1 in the malignant cells of hairy cell leukemia.

Authors:  Joseph R Slupsky; Aura S Kamiguti; Robert J Harris; John C Cawley; Mirko Zuzel
Journal:  Am J Pathol       Date:  2007-02       Impact factor: 4.307

3.  DNA damage signaling and p53-dependent senescence after prolonged beta-interferon stimulation.

Authors:  Olga Moiseeva; Frédérick A Mallette; Utpal K Mukhopadhyay; Adrian Moores; Gerardo Ferbeyre
Journal:  Mol Biol Cell       Date:  2006-01-25       Impact factor: 4.138

4.  Mitochondrially localized ERK2 regulates mitophagy and autophagic cell stress: implications for Parkinson's disease.

Authors:  Ruben K Dagda; Jianhui Zhu; Scott M Kulich; Charleen T Chu
Journal:  Autophagy       Date:  2008-06-16       Impact factor: 16.016

5.  Active ERK2 is sufficient to mediate growth arrest and differentiation signaling.

Authors:  Pui-Kei Wu; Seung-Keun Hong; Seung-Hee Yoon; Jong-In Park
Journal:  FEBS J       Date:  2015-02-03       Impact factor: 5.542

6.  ERK-mediated phosphorylation of TFAM downregulates mitochondrial transcription: implications for Parkinson's disease.

Authors:  Kent Z Q Wang; Jianhui Zhu; Ruben K Dagda; Guy Uechi; Salvatore J Cherra; Aaron M Gusdon; Manimalha Balasubramani; Charleen T Chu
Journal:  Mitochondrion       Date:  2014-04-24       Impact factor: 4.160

7.  Determinants that control the specific interactions between TAB1 and p38alpha.

Authors:  Huamin Zhou; Min Zheng; Jianming Chen; Changchuan Xie; Anand R Kolatkar; Tyler Zarubin; Zhiyun Ye; Radha Akella; Shengcai Lin; Elizabeth J Goldsmith; Jiahuai Han
Journal:  Mol Cell Biol       Date:  2006-05       Impact factor: 4.272

8.  Combination of two activating mutations in one HOG1 gene forms hyperactive enzymes that induce growth arrest.

Authors:  Gilad Yaakov; Michal Bell; Stefan Hohmann; David Engelberg
Journal:  Mol Cell Biol       Date:  2003-07       Impact factor: 4.272

9.  Isolation of intrinsically active (MEK-independent) variants of the ERK family of mitogen-activated protein (MAP) kinases.

Authors:  Vered Levin-Salomon; Konstantin Kogan; Natalie G Ahn; Oded Livnah; David Engelberg
Journal:  J Biol Chem       Date:  2008-10-01       Impact factor: 5.157

10.  Erk1/2 MAP kinases are required for epidermal G2/M progression.

Authors:  Phillip A Dumesic; Florence A Scholl; Deborah I Barragan; Paul A Khavari
Journal:  J Cell Biol       Date:  2009-05-04       Impact factor: 10.539

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.